• Декскетопрофен – инструмент периоперационного обезболивания 
К содержанию

Декскетопрофен – инструмент периоперационного обезболивания 

HEALTH OF WOMAN.2015.3(99):47–52 
 

Декскетопрофен – инструмент периоперационного обезболивания 
 

Сокологорский С. В.

ГБОУ ВПО Первый Московский государственный медицинский университет им. И.М. Сеченова Минздрава России

Гинекология. 2014; 5: 17-22 
 

Проблема послеоперационного обезболивания, несмотря на постоянно проводимый поиск оптимальных методов и технологий, остается далека от своего разрешения. Спектр анальгетических средств, имеющихся в арсенале анестезиологов и врачей других хирургических специальностей, не всегда используется эффективно и целесообразно. Традиционное применение опиатных анальгетиков в послеоперационный период нередко осложняет его течение и ухудшает результаты хирургического лечения. Нестероидные противовоспалительные препараты, обладая как анальгетической, так и противовоспалительной активностью, могут быть успешно включены в мультимодальные схемы послеоперационного обезболивания и рассматриваться как компонент интенсивной терапии. В статье приведен обзор литературных источников, посвященных применению декскетопрофена – S(+)-кетопрофен – в периоперационный период, рассмотрены схемы его использования в качестве компонента мультимодального обезболивания. 
 

Ключевые слова: декскетопрофен, кетопрофен, нестероидные противовоспалительные препараты, послеоперационное обезболивание. 
 

Литература: 

1. Api O, Ergen B, Api M et al. 2010. Comparison of oral nonsteroidal analgesic and intrauterine local anesthetic for pain relief in uterine fractional curettage: a randomized, double-blind, placebo-controlled trial. Am J Obstet Gynecol. 203(1):28.e1–7.

2. Barbanoj M, Rosa R, Arbos A, Rico Amaro S. 2008. Dexketoprofentrometamol: clinical evidence supporting its role as painkiller. Expert Rev Neurother 8:1625–40. http://dx.doi.org/10.1586/14737175.8.11.1625; PMid:18986233

3. Barden J, Derry S, McQuay HJ, Moore RA. 2009. Single dose oral ketoprofen and dexketoprofen for acute postoperative pain in adults. Cochrane Database Syst Rev 7(4): CD007355.

4. Benhamou D, Berti M, Brodner G. 2008. Postoperative analgesic therapy observational survey (PATHOS): a practice pattern study in 7 Central/Southern European countries. Pain 136:134–41. http://dx.doi.org/10.1016/j.pain.2007.06.028; PMid:17703887

5. Biki B, Mascha E, Moriarty D. 2008. Anesthetic technique for radical prostatectomy surgery affects cancer recurrence: a retrospective analysis. Anesthesiology 109:180–7. http://dx.doi.org/10.1097/ALN.0b013e31817f5b73; PMid:18648226

6. Chao C, Hu S, Molitor T. 1992. Morphine potentiates transforming growth factor-beta release from human peripheral blood mononuclear cell cultures. J Pharmacol Exp Ther 262:19–24.

7. Coley K, Williams B, DaPos S. 2002. Retrospective evaluation of unanticipated admissions and readmissions after same day surgery and associated costs. J Clin Anest 14:349–53. http://dx.doi.org/10.1016/S0952-8180(02)00371-9

8. Debre B. 2000. A double-blind (observer blind), randomised trial comparing the analgesic efficacy and safety of dexketoprofentrometamol (50 mg) with ketoprofen (100 mg) given as an intravenous infusion, in patients with renal or uretal colic. Clin Trial Report.

9. Green GA. Understanding NSAIDs: from aspirin to COX-2. Clin Cornerstone 20013. 5:50–60.

10. Harrison F. 2001. Double-blind randomised, parallel-group comparison of the safety and efficacy of oral dexketoprofen 25 mg with tramadol 50 mg in subjects with moderate to severe pain following orthopaedic surgery. Clin Trial Report.

11. Jackson ID, Heidemann BH, Wilson J et al. 2004. Doubleblind, randomized, placebo-controlled trial comparing rofecoxib with dexketoprofentrometamol in surgical dentistry. Br J Anaesth 92:675–80. http://dx.doi.org/10.1093/bja/aeh131; PMid:15033894

12. Jamali F, Brocks DR. 1990a. Clinical pharmacokinetics of ketoprofen and its enantiomers. Clin Pharmacokinet 19(3):197–217.

13. Laulin J-P, Maurette P, Rivat C. 2002. The role of ketamine in preventing fentanyl-unducedhyperalgesia and subsequent acute morphine tolerance. Anesth Analg 94:1263–9. http://dx.doi.org/10.1097/00000539-200205000-00040

14. Leman P, Kapadia Y, Herington J. 2003. Randomised controlled trial of the onset of analgesic efficacy of dexketoprofen and diclofenac in lower limb injury. Emerg Med J 20:511–3. http://dx.doi.org/10.1136/emj.20.6.511; PMid:14623834 PMCid:PMC1726222

15. Larcher A, Laulin J-P, Celerier E. 1998. Acute tolerance associated with a single opiate administration: involvement of N-methyl-D-aspartate-dependent pain facilitatory systems. Neuroscience 84:583–9. http://dx.doi.org/10.1016/S0306-4522(97)00556-3

16. Osiri M, Moreland LW. 1999. Specific cyclooxygenase 2 inhibitors: a new choice of nonsteroidal anti-inflammatory drug therapy. Arthritis Care Res. 12(5):351–62. http://dx.doi.org/10.1002/1529-0131(199910)12:5<351::AID-ART7>3.0.CO;2-L

17. Marenco JL, Perez M, Navarro FJ et al. 2000. A multicentre, randomised, double-blind study to compare the efficacy and tolerability of dexketoprofen trometamol versus diclofenac in the symptomatic treatment of knee osteoarthritis. Clin Drug Invest 19:247–56. http://dx.doi.org/10.2165/00044011-200019040-00002

18. McCormack K, Urquhart E. 1995. Correlation 11 between nonsteroidal anti-infammator y drug effcacy in a clinical pain model and the dissociation of their anti-infammatory and analgesic proper ties in animals models. Clin Drug Investig 9:88–97. http://dx.doi.org/10.2165/00044011-199509020-00005

19. Merskey H, Bugduk N. 1994. Classification of Chronic Pain. Descriptions of Chronic Pain Syndromes and Definitions of Pain Terms. Seattle: WA, IASP Press.

20. Moore RA, Barden J. 2008. Systematic review of dexketoprofen in acute and chronic pain BMC. Clin Pharmacol.

21. Peat S, Paredes I et al. 2002. Dexketoprofen trometamol versus tramadol in the relief of pain following ajororthopaedic surgery. 10th World Congress on Pain, IASP, San Diego, California.

22. Polomano R, Dunwoody C, Krenzischer D. 2008. Perspective on pain management in the 21st century. Pain Management Nurs 9:3–10. http://dx.doi.org/10.1016/j.pmn.2007.11.002; PMid:18294589

23. Sanchez-Carpena J, Sesma-Sanchez J, Sanchez-Juan C et al. 2003b. Comparison of dexketoprofen trometamol and dipyrone in the treatment of renal colic. Clin Drug Invest 23:139–52.

24. Sanchez-Carpena J, Dominguez-Hervella F et al. 2003a. Intravenous dexketoprofen compared to metamizole followed by oral treatment in acute renal colic. Annual Scientific Meeting, Glasgow 2003. The Pain Society (The British Chapter of ISAP)

25. Schreiber M. 1996. Double-blind, randomised, parallel-group comparison of the safety and efficacy of single oral doses of dexketoprofen tromethamine salt (LM-1158.tris, 12,5 mg or 25 mg) with racemic ketorpofen (50 mg) and placebo in patients with moderate to severe pain following orthopaedic surgery. Clin Trial Report.

26. Steinmeyer J. 2000. Pharmacological basis for the therapy of pain and inflammation with nonsteroidal anti-inflammatory drugs. Arthritis Res 2(5):379–85. http://dx.doi.org/10.1186/ar116 
PMid:11094452 PMCid:PMC130140

27. Tokgoz H, Yurtlu S, Hanci V et al. 2010. Comparison of the analgesic effects of dexketoprofen and diclofenac during shockwave lithotripsy: a randomized, double-blind clinical trial. J Endourol. 24(6):1031-5. http://dx.doi.org/10.1089/end.2009.0257

28. Tuncer S, Tavlan A, Kostekci H et al. 2006. Postoperatifaрrida deksketoprofen kullanimi. Agri. 18:30–5.

29. Vane JR. 1971. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol. 231(25):232–5.

30. Vallйs J, Artigas R et al. 2006a. Single and repeated dose pharmacokinetics of dexketoprofen trometamol in patients with impaired liver function. Methods Find Exp Clin Pharmacol; 28 (Suppl. A):29–36.

31. Vallйs J, Artigas R et al. 2006b. Single and repeated dose pharmacokinetics of dexketoprofen trometamol in young and elderly subjects. Methods Find Exp Clin Pharmacol; 28 (Suppl. A):13–9.

32. Vallйs J, Artigas R et al. 2006c. Clinical pharmacokinetics of parenteral dexketoprofen trometamol in healthy subjects. Methods Find Exp Clin Pharmacol; 28 (Suppl. A):7–12.

33. Vallйs J, Artigas R et al. 2006d. Pharmacokinetics of dexketoprofen trometamol in subjects with mild and moderate chronic renal insufficiency. Methods Find Exp Clin Pharmacol; 28 (Suppl. A):21–8.

34. Vidal F, Martinez P, Montero A et al. 1999. Clinical trial to assess the analgesic efficacy and safety of LM-1158.TRIS (12.5 and 25 mg tid) versus ketoprofen (50 mg tid) and placebo after oral administration in patients with acute post-surgery pain. Clin Trial Report.

35. Zippel H, Wagenitz A. 2006. Comparison of the efficacy and safety of intravenously administered dexketoprofen trometamol and ketoprofen in the management of pain after orthopaedic surgery: a multicentre, double-blind, randomised, parallel-group clinical trial. Clin Drug Investig 26(9):517–28. http://dx.doi.org/10.2165/00044011-200626090-00005; PMid:17163285

36. Zeilhofer HU, Brune K. 2006. Analgesic strategies beyond the inhibition of cyclooxygenases. Trends Pharmacol Sci. 27(9):467–74. http://dx.doi.org/10.1016/j.tips.2006.07.007; PMid:16876882

37. Simmons DL, Botting RM, Hla T. 2004. Cyclooxygenaseisozymes: the biology of prostaglandin synthesis and inhibition. Pharmacol Rev 56:387–437. http://dx.doi.org/10.1124/pr.56.3.3; PMid:15317910